Literature DB >> 10215072

Fetal loss in Down syndrome pregnancies.

J K Morris1, N J Wald, H C Watt.   

Abstract

It is recognized that pregnancies with Down syndrome are liable to end in spontaneous fetal loss. It is important to determine the magnitude of this effect so that it can be taken into account when assessing the results of antenatal screening programmes for Down syndrome. Failure to do so will tend to overestimate the detection rate in intervention studies in which the screening results are used to identify women for a diagnostic test and the offer of a termination of pregnancy if indicated. We present new data on the spontaneous fetal loss in Down syndrome pregnancies from the National Down Syndrome Cytogenetic Register (1989-1996). We compare our results with published results of other studies on the subject to obtain a summary estimate. We exclude one study from the meta analysis due to incorrect methodology resulting in an overestimate of fetal loss. Based on the combined data (i) between the time of chorionic villus sampling and term an estimated 43 per cent (95 per cent CI: 31-54 per cent) of pregnancies ended in a miscarriage or still birth, (ii) between the time of amniocentesis and term an estimated 23 per cent (95 per cent CI: 19 28 per cent) of pregnancies ended in a miscarriage or still birth, and (iii) 12 per cent (95 per cent CI: 2-23 per cent) of births were stillborn or resulted in a neonatal death.

Entities:  

Mesh:

Year:  1999        PMID: 10215072

Source DB:  PubMed          Journal:  Prenat Diagn        ISSN: 0197-3851            Impact factor:   3.050


  34 in total

1.  Autopsy after termination of pregnancy for fetal anomaly: retrospective cohort study.

Authors:  P A Boyd; F Tondi; N R Hicks; P F Chamberlain
Journal:  BMJ       Date:  2003-12-08

2.  Trisomy recurrence: a reconsideration based on North American data.

Authors:  Dorothy Warburton; Louis Dallaire; Maya Thangavelu; Lori Ross; Bruce Levin; Jennie Kline
Journal:  Am J Hum Genet       Date:  2004-07-08       Impact factor: 11.025

3.  The National Down Syndrome Project: design and implementation.

Authors:  Sallie B Freeman; Emily G Allen; Cindy L Oxford-Wright; Stuart W Tinker; Charlotte Druschel; Charlotte A Hobbs; Leslie A O'Leary; Paul A Romitti; Marjorie H Royle; Claudine P Torfs; Stephanie L Sherman
Journal:  Public Health Rep       Date:  2007 Jan-Feb       Impact factor: 2.792

4.  Postnatal lethality and cardiac anomalies in the Ts65Dn Down syndrome mouse model.

Authors:  Clara S Moore
Journal:  Mamm Genome       Date:  2006-10-03       Impact factor: 2.957

5.  Perinatal loss of Ts65Dn Down syndrome mice.

Authors:  Randall J Roper; Heidi K St John; Jessica Philip; Ann Lawler; Roger H Reeves
Journal:  Genetics       Date:  2005-09-19       Impact factor: 4.562

6.  To transfer or not to transfer: the case of comprehensive chromosome screening of the in vitro embryo.

Authors:  Kristien Hens
Journal:  Health Care Anal       Date:  2015-06

7.  Cardiovascular development and survival during gestation in the Ts65Dn mouse model for Down syndrome.

Authors:  Candice G Lorandeau; Lauren A Hakkinen; Clara S Moore
Journal:  Anat Rec (Hoboken)       Date:  2010-11-16       Impact factor: 2.064

8.  Down syndrome critical region-1 is a transcriptional target of nuclear factor of activated T cells-c1 within the endocardium during heart development.

Authors:  Hai Wu; Shih-chu Kao; Tomasa Barrientos; Scott H Baldwin; Eric N Olson; Gerald R Crabtree; Bin Zhou; Ching-Pin Chang
Journal:  J Biol Chem       Date:  2007-08-10       Impact factor: 5.157

Review 9.  Pluripotent stem cells in disease modelling and drug discovery.

Authors:  Yishai Avior; Ido Sagi; Nissim Benvenisty
Journal:  Nat Rev Mol Cell Biol       Date:  2016-01-28       Impact factor: 94.444

10.  Noninvasive Prenatal Testing for Trisomies 21, 18, and 13, Sex Chromosome Aneuploidies, and Microdeletions: A Health Technology Assessment.

Authors: 
Journal:  Ont Health Technol Assess Ser       Date:  2019-02-19
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.